JDP Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsJDP Therapeutics

JDP Therapeutics

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Quzyttir	Cetirizine	2019-10-04	2030-2032	Allergic rhinitis perennial , Urticaria , Sinusitis , Asthma , Common cold

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

multiple sclerosis

,

healthy volunteers/patients

,

diabetes mellitus

,

type 1 diabetes mellitus

,

migraine disorders

,

,

major depressive disorder

,

,

multiple myeloma

,

plasma cell neoplasms

,

castleman disease

,

,

depressive disorder

,

treatment-resistant depressive disorder

,

colorectal neoplasms

,

,

rectal neoplasms

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

squamous cell neoplasms

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

,

central nervous system neoplasms

,

nervous system neoplasms

,

breast neoplasms

,

,

vision disorders

,

,

non-small-cell lung carcinoma

,

,

,

bcr-abl positive chronic myelogenous leukemia

,

myeloid leukemia

,

,

,

,

,

spondylarthritis

,

,

psoriatic arthritis

,

ankylosing spondylitis

,

retinal vein occlusion

,

,

chronic urticaria

,

,

neoplasm metastasis

,

,

philadelphia chromosome

,

cystic fibrosis

,

,

choroidal neovascularization

,

pathologic neovascularization

,

renal cell carcinoma

,

ovarian neoplasms

,

pituitary acth hypersecretion

,

acth-secreting pituitary adenoma

,

,

,

myelodysplastic syndromes

,

,

thrombocytopenia

,

retinal diseases

,

diabetic retinopathy

,

macular degeneration

,

,

sickle cell anemia

,

,

,

,

neuroendocrine tumors

,

b-cell lymphoma

,

,

gastrointestinal stromal tumors

,

ovarian epithelial carcinoma

,

triple negative breast neoplasms

,

myeloid leukemia acute

,

,

,

pseudomonas aeruginosa

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

prostatic neoplasms

,

giant cell arteritis

,

polymyalgia rheumatica

,

myelomonocytic leukemia chronic

,

myelomonocytic leukemia juvenile

,

wet macular degeneration

,

brain neoplasms

,

cutaneous malignant melanoma

,

,

hepatocellular carcinoma

,

stomach neoplasms

,

large b-cell lymphoma diffuse

,

carcinoid tumor

,

malignant carcinoid syndrome

,

serotonin syndrome

,

,

hypercholesterolemia

,

hyperlipoproteinemia type ii

,

homozygous familial hypercholesterolemia

,

lupus nephritis

,

,

axial spondyloarthritis

,

endometrioid carcinoma

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

allergic rhinitis

,

,

allergic rhinitis seasonal

,

graft vs host disease

,

primary myelofibrosis

,

,

inclusion body myositis

,

juvenile arthritis

,

hereditary autoinflammatory diseases

,

,

familial mediterranean fever

,

retinal neovascularization

,

rheumatoid arthritis

,

,

hyperlipoproteinemia type i

,

degenerative myopia

,

,

non-hodgkin lymphoma

,

,

pulmonary infarction

,

hodgkin disease

,

behcet syndrome

,

respiratory aspiration

,

,

,

,

hypersensitivity

,

food hypersensitivity

,

follicular lymphoma

,

polycythemia vera

,

,

,

myeloid leukemia chronic-phase

,

,

,

essential hypertension

,

systolic murmurs

,

disease progression

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use